Jinling Pharmaceutical Co. Ltd. A | Ownership
Companies that own Jinling Pharmaceutical Co. Ltd. A
AEGON-INDUSTRIAL Fund Management Co., Ltd.
35,298,954
7.02%
26,728,954
0.64%
12/31/2016
China Investment Corp. (Investment Management)
13,840,600
2.75%
0
0.04%
12/31/2016
China Life Asset Management Co., Ltd.
3,263,321
0.65%
-6,523,399
0.04%
12/31/2016
Great Wall Fund Management Co., Ltd.
3,199,975
0.64%
3,199,975
0.2%
12/31/2016
Harvest Fund Management Co., Ltd.
2,731,288
0.54%
0
0.02%
12/31/2017
The Vanguard Group, Inc.
1,296,683
0.26%
0
0%
07/31/2018
China Southern Asset Management Co., Ltd.
696,763
0.14%
517,269
0.01%
12/31/2017
Everbright Pramerica Fund Management Co., Ltd.
133,800
0.03%
119,200
0.01%
12/31/2017
Tebon Fund Management Co. Ltd.
91,091
0.02%
0
0.04%
12/31/2017
Truvalue Asset Management Co. Ltd.
58,000
0.01%
-274,800
0%
12/31/2017
| Address |
Jinling Pharmaceutical Building
Nanjing Jiangsu 210009
China
|
|
Employees
|
- |
| Website |
- |
| Updated |
07/08/2019 |
| Jinling Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. It involves in the preparations, production, and sale of western medicine raw materials, biochemical products, pharmaceutical packaging products, medical instruments, healthy food, natural beverages, and medical equipment. The company was founded on September 8, 1998 and is headquartered in Nanjing, China. |
